Related Experiment Video

Updated: Oct 1, 2025

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

3.1K

SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis

Jianxin Zhang1, Yanbing Shen1, Dandan Ma2

  • 1Department of General Surgery, General Hospital of Central Theater Command, Wuhan 430070, Hubei, China.

Open Medicine (Warsaw, Poland)
|March 2, 2022
PubMed

Insights

Long non-coding RNA SLCO4A1-AS1 promotes pancreatic cancer (PC) progression by upregulating KIF21B via sponging miR-4673. Knockdown of SLCO4A1-AS1 inhibits PC cell growth, migration, and invasion, while promoting apoptosis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Pancreatic cancer (PC) remains a significant health challenge with limited therapeutic options.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development.
  • The specific function of lncRNA SLCO4A1-AS1 in PC is not well understood.

Purpose of the Study:

  • To elucidate the biological significance and molecular mechanism of lncRNA SLCO4A1-AS1 in pancreatic cancer.
  • To investigate the role of SLCO4A1-AS1 in regulating PC cell proliferation, migration, invasion, and apoptosis.

Main Methods:

  • Cell proliferation, migration, invasion, and apoptosis assays (CCK-8, colony formation, wound healing, Transwell, flow cytometry).
  • Bioinformatics analysis, RNA immunoprecipitation (RIP), luciferase reporter assays, and RNA pull-down assays.
  • Investigation of the interaction between SLCO4A1-AS1, miR-4673, and KIF21B.

Main Results:

  • SLCO4A1-AS1 expression was significantly upregulated in pancreatic cancer tissues and cell lines.
  • Knockdown of SLCO4A1-AS1 suppressed PC cell proliferation, migration, and invasion, and induced apoptosis.
  • SLCO4A1-AS1 directly binds to miR-4673, acting as a molecular sponge, and upregulates KIF21B expression.

Conclusions:

  • SLCO4A1-AS1 functions as an oncogenic lncRNA in pancreatic cancer.
  • The SLCO4A1-AS1/miR-4673/KIF21B axis plays a critical role in promoting pancreatic cancer progression.
  • SLCO4A1-AS1 represents a potential therapeutic target for pancreatic cancer treatment.
Keywords:
KIF21BSLCO4A1-AS1miR-4673pancreatic cancer

More Related Videos

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models03:42

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Published on: September 27, 2024

1.6K
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

6.6K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K